The role of biomarkers of hypercoagulability: Evaluating thrombosis risk and outcomes in cancer patients
用户mKQO0T3T2ANY
14天前
46
10
已关闭
DOI:
文献链接:
其他信息:
PG Rosas
2026
cris.maastrichtuniversity.nl
40 天前 - … with non-small cell lung cancer (NSCLC). Additionally, this … breast cancer, whereas
high-sensitivity CRP and D-dimer … as a marker of cancer recurrence underscores the overall …

